![Aeterna Zentaris Inc. Soars](https://microsmallcap.com/wp-content/uploads/2018/01/Hot-stocks-today-Aeterna-Zentaris-Inc.-soars-on-huge-drug-deal-374x295.jpg)
Biotechnology
Hot Stocks Today: Aeterna Zentaris Inc. Soars on Huge Drug Deal
Shares in Aeterna Zentaris Inc. (TSX:AEZS) (NASDAQ:AEZS) have shot up 37% today as values rose from $2.08 yesterday closing time to a peak of $2.85 at 9:45 EST this morning. This comes on the heels of a ... [Read]
![Sangamo Expansion Strategies](https://microsmallcap.com/wp-content/uploads/2018/01/Sangamo-Expansion-Strategies-Are-Working-Shares-Rallied-Above-300-Last-Year-374x295.jpg)
Biotechnology
Sangamo Expansion Strategies Are Working, Shares Rallied Above 300% Last Year
With a market capitalization of $1.5 billion, Sangamo Therapeutics (NASDAQ:SGMO) continues to impress investors with its expansion strategies. Sangamo recently announced its partnership with Pfizer (NYSE:PFE), with an aim to develop a gene therapy to treat ... [Read]
![Top Performer Marinus Pharmaceuticals](https://microsmallcap.com/wp-content/uploads/2018/01/The-Top-Performer-Marinus-Pharmaceuticals-Has-More-Upside-374x295.png)
Biotechnology
Top Performer Marinus Pharmaceuticals Has More Upside
Marinus Pharmaceuticals (NASDAQ:MRNS) holds the first spot in terms of its stock price performance last year. MRNS stock rallied above 800% before the latest selloff. Marinus stock price soared from $1.25 at the beginning of ... [Read]
![](https://microsmallcap.com/wp-content/uploads/2018/01/Is-Amarin-Stock-Rally-Offers-a-Selling-Opportunity-374x295.png)
Biotechnology
Does the Amarin Stock Rally Offer a Selling Opportunity?
Amarin Corporation (NASDAQ:AMRN) investors are cheering several impressive reports related to the company’s financial and operational performance, which has led the stock price to rally above 29% in the last month alone. However, traders are ... [Read]
![Concert Pharmaceuticals Seeing Red](https://microsmallcap.com/wp-content/uploads/2018/01/Concert-Pharmaceuticals-Seeing-Red-Stock-Down-Nearly-30-After-PTAG-Rejects-its-Grant-374x295.png)
Biotechnology
Concert Pharmaceuticals Seeing Red; Stock Down Nearly 30% After PTAG Rejects its Grant
Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) is seeing red. The market closes in twenty minutes, which doesn’t give the Lexington, Massachusetts-based company enough time to try and make a comeback. As of this writing, Concert Pharmaceuticals is ... [Read]
![prconnect, editorial, Healthcare, healthcare investing, investing in healthcare, healthcare investments, investing in healthcare mutual funds, investor healthcare, healthcare stocks to invest in, invest in healthcare, healthcare investor, healthcare investment, healthcare stocks today, healthcare investors, healthcare investment bank, healthcare mutual funds, healthcare savings, medicine stocks, healthcare industry companies, medical stocks, healthcare stock, health sector stocks, healthcare stock market, health services stocks, biotech investing, biotech investing news, biotech investments, biotech companies, investing in biotech companies, investing in biotech stocks, biotech invest, biotech investors, new biotech stocks, biotech stocks today, top biotech investors, investing in biotech, biotech sector etf, biotech stock analysis, biotech stocks, invest in biotech, best biotech companies to invest in, biotech stock research, biotech stock market. biotech investment, editorial](https://microsmallcap.com/wp-content/uploads/2018/01/TG-Therapeutics-Climbs-By-14-After-Presenting-at-J.P-Morgan-Healthcare-Conference-374x295.jpg)
Biotechnology
TG Therapeutics Climbs By 14% After Presenting at J.P Morgan Healthcare Conference
TG Therapeutics, Inc. (NASDAQ:TGTX) today participated in the 36th Annual J.P Morgan Healthcare Conference in San Francisco and as a result, the stock has increased by almost 15%. TG Therapeutics is a biopharmaceutical company engaged ... [Read]
![](https://microsmallcap.com/wp-content/uploads/2018/01/Novavax-shares-shoot-up-over-50-amid-promising-trial-developments-374x295.png)
Biotechnology
Novavax Shares Shoot Up Over 50% Amid Promising Trial Developments
Biotech company Novavax (NASDAQ:NVAX) is enjoying a share rise of 59.40% as of 4:00 PM EST today on the heels of announcing encouraging results in an immunization study. This brings their share value up from ... [Read]
![Akers Biosciences](https://microsmallcap.com/wp-content/uploads/2018/01/Akers-Biosciences-stock-soaring-but-why-374x295.png)
Health
Akers Biosciences stock soaring – but why?
It’s pharma fever on the stock market today as the likes of Diffusion Pharmaceuticals (NASDAQ:DFFN) and most notably Pain Therapeutics (NASDAQ:PTIE) have seen stock climb by 42.98% and 114.22% respectively. These heady rises come amid ... [Read]
![Spectrum Pharmaceutical Stock](https://microsmallcap.com/wp-content/uploads/2018/01/More-Upside-is-Ahead-for-Spectrum-Pharmaceutical-Stock-374x295.png)
Biotechnology
More Upside is Ahead for Spectrum Pharmaceutical Stock
Spectrum Pharmaceuticals Inc (NASDAQ:SPPI) has generated substantial share price appreciation in the last twelve months, due to its strategy of developing drugs in Hematology and Oncology. It currently offers six oncology and hematology drugs, and ... [Read]
![Axsome Therapeutics shares drop](https://microsmallcap.com/wp-content/uploads/2018/01/Axsome-Therapeutics-shares-droop-following-disappointing-drug-trial-outcome-374x295.png)
Biotechnology
Axsome Therapeutics Shares Drop Following ‘Disappointing’ Drug Trial Outcome
It’s a gray morning for Axsome Therapeutics. Shares in the biopharmaceutical company have fallen by -36.94%, bringing the last price to 3.50 as of 2:38 PM EST. The sink comes amid reports that their trial ... [Read]